How is semaglutide classified?
It is classified as a GLP-1 receptor agonist — a single-target incretin analogue. Two structural features define it in the literature: an Aib substitution at position 8 that blocks enzymatic cleavage, and C18 diacid acylation for extended circulation.
How is its mechanism studied?
- Glucose-dependent insulin secretion in islet and rodent models.
- Central GLP-1 receptor populations studied in appetite-signalling research.
- Gastric emptying and nutrient-transit endpoints in animal and human study designs.
What kind of research exists?
Semaglutide has the deepest publication record of the compounds in this library — receptor pharmacology, preclinical models, large randomised trials and a growing body of independent secondary analysis. For research teams it therefore functions as the reference point the newer multi-agonists are measured against.
What is it studied alongside?
Routinely compared with tirzepatide and retatrutide in receptor-coverage comparisons, and with amylin analogues such as cagrilintide in combination research.
How does Neo Labs supply and handle it?
Lyophilised, sealed, HPLC-verified with a batch COA tied to the lot on the label. Cold and light-protected storage.